Home/Filings/4/0000899243-17-008160
4//SEC Filing

Aerpio Pharmaceuticals, Inc. 4

Accession 0000899243-17-008160

$WHWKCIK 0001422142operating

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:41 PM ET

Size

4.6 KB

Accession

0000899243-17-008160

Insider Transaction Report

Form 4
Period: 2017-03-15
PETERS KEVIN G.
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2017-03-15$5.00/sh+3,642$18,210320,536 total

Issuer

Aerpio Pharmaceuticals, Inc.

CIK 0001422142

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001422142

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:41 PM ET
Size
4.6 KB